Illumina Sells 30 More Genome Analyzers to Broad Institute

The company also reaffirmed its revenue guidance of a minimum of $165 million for the fourth quarter of 2009.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.